Anaplastic Oligodendroglioma Clinical Trials

55 clinical trials for Anaplastic Oligodendroglioma across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas — RECRUITING · PHASE2
• Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas — RECRUITING · PHASE1
• A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma — RECRUITING · PHASE1
• Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms — RECRUITING · PHASE1
• Implantable Microdevice In Primary Brain Tumors — RECRUITING · PHASE1
• Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma — ACTIVE_NOT_RECRUITING · PHASE2
• Pediatric Long-Term Follow-up and Rollover Study — ACTIVE_NOT_RECRUITING · PHASE4
• A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma — ACTIVE_NOT_RECRUITING
• Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors — TERMINATED
• Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) — COMPLETED · PHASE1
• INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas — COMPLETED · PHASE1
• Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas — TERMINATED
• Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma — COMPLETED · PHASE1
• SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors — COMPLETED · PHASE1
• Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children — COMPLETED · PHASE1
• Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors — COMPLETED · PHASE2
• Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma — TERMINATED · PHASE1
• Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas — TERMINATED · PHASE1
• Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas — COMPLETED · PHASE1
• Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas — TERMINATED · PHASE1
• Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma — COMPLETED · PHASE1
• Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors — COMPLETED · PHASE1
• RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas — COMPLETED · PHASE1
• Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors — COMPLETED · PHASE1
• NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma — WITHDRAWN · NA
• Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme — COMPLETED · PHASE1
• AZD8055 for Adults With Recurrent Gliomas — COMPLETED · PHASE1
• Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma — COMPLETED · PHASE1
• Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme. — WITHDRAWN
• (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas — TERMINATED
• Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor — COMPLETED · PHASE1
• A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma — COMPLETED · PHASE1
• Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor — COMPLETED · PHASE1
• Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma — COMPLETED · PHASE2
• Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma — TERMINATED · PHASE1
• p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors — COMPLETED · PHASE1
• Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma — COMPLETED · PHASE1
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors — COMPLETED · PHASE1
• Expanded Access to ANG1005 for Individual Patients — TERMINATED
• Cellular Immunotherapy Study for Brain Cancer — COMPLETED · PHASE1
• Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial — COMPLETED · PHASE2
• A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas — COMPLETED · PHASE2
• Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors — COMPLETED · PHASE2
• Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 — COMPLETED · PHASE1
• Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms — COMPLETED · PHASE2
• A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas — COMPLETED · PHASE1
• Sorafenib in Newly Diagnosed High Grade Glioma — COMPLETED · PHASE1
• BIBF 1120 for Recurrent High-Grade Gliomas — COMPLETED · PHASE2
• Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma — TERMINATED · PHASE2

Refine this search